Related Experiment Video
Updated: Aug 8, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Antitumor activity of IFN-lambda in murine tumor models
Atsuko Sato1, Mamitaro Ohtsuki, Megumi Hata
1Division of Organ Replacement Research, Center for Molecular Medicine, Jichi Medical School, Shimotsuke, Tochigi, Japan.
Journal of Immunology (Baltimore, Md. : 1950)
|June 6, 2006
Summary
Interferon-lambda (IFN-lambda) demonstrates significant antitumor activity by inducing cancer cell apoptosis and activating natural killer (NK) cells. This cytokine shows promise as an adjunctive therapy for various human malignancies.
Area of Science:
- Immunology
- Oncology
- Virology
Background:
- Interferon-lambda (IFN-lambda) subtypes 1, 2, and 3 are class II cytokines with known antiviral properties.
- The potential antitumor effects of IFN-lambda in cancer treatment remain largely unexplored.
Purpose of the Study:
- To investigate the antitumor activity of mouse IFN-lambda in murine B16 melanoma and Colon26 cancer models.
- To elucidate the mechanisms underlying IFN-lambda-mediated tumor suppression.
Main Methods:
- Transduction of murine cancer cell lines with mouse IFN-lambda.
- In vitro analysis of cellular changes including MHC class I expression, apoptosis markers, and cell cycle regulators.
- In vivo studies assessing tumor formation and growth inhibition.
- Immune cell profiling and depletion assays to identify key immune players.
- Hydrodynamic injection of IFN-lambda cDNA for liver metastasis models.
Main Results:
- IFN-lambda overexpression upregulated MHC class I and Fas/CD95, increased caspase-3/7 activity, and modulated p21(Waf1/Cip1) and Rb phosphorylation in B16 cells.
- IFN-lambda significantly inhibited subcutaneous and metastatic tumor growth in vivo.
- IFN-lambda induced lymphocytic infiltrates, with NK cells being crucial for tumor growth inhibition.
- Local IFN-lambda delivery in the liver reduced tumor burden and mortality, enhancing NK/NKT cell activity.
Conclusions:
- IFN-lambda exhibits dual antitumor mechanisms: direct induction of tumor apoptosis and NK cell-mediated immune destruction.
- Innate immune responses, particularly involving NK cells, are critical for IFN-lambda's antitumor efficacy.
- Local administration of IFN-lambda represents a potential adjunctive therapeutic strategy for human malignancies.
